Manufacturer of Controlled Substances; Notice of Registration, 70989-70990 [E6-20737]

Download as PDF 70989 Federal Register / Vol. 71, No. 235 / Thursday, December 7, 2006 / Notices Schedule Drug Lysergic Acid Diethylamide (7315) ... Tetrahydrocannabinol (7370) ............ Alphamethadol (9605) ....................... Phencyclidine (7471) ......................... Ecgonine (9180) ................................ Methadone (9250) ............................. Morphine (9300) ................................ I I I II II II II The company plans to manufacture small quantities of listed controlled substances for use in diagnostic products. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Roche Diagnostics Operations, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Roche Diagnostics Operations, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: November 28, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–20697 Filed 12–6–06; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration sroberts on PROD1PC70 with NOTICES Importer of Controlled Substances; Notice of Registration By Notice dated August 14, 2006 and published in the Federal Register on August 21, 2006, (71 FR 48556–48557), Sigma Aldrich Manufacturing LLC., Subsidiary of Sigma Aldrich Manufacturing Company, 3500 Dekalb Street, St. Louis, Missouri 63118, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule I and II: VerDate Aug<31>2005 18:18 Dec 06, 2006 Jkt 211001 Drug Schedule Cathinone (1235) .......................... Methcathinone (1237) .................. Aminorex (1585) ........................... Gamma Hydroxybutyric Acid (2010). Methaqualone (2565) ................... Ibogaine (7260) ............................ Lysergic acid diethylamide (7315) Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ..... Mescaline (7381) .......................... 4-Bromo-2,5dimethoxyamphetamine (7391). 4-Bromo-2,5dimethoxyphenethylamine (7392). 4-Methyl-2,5dimethoxyamphetamine (7395). 2,5-Dimethoxyamphetamine (7396). 3,4-Methylenedioxyamphetamine (7400). N-Hydroxy-3,4methylenedioxyamphetamine (7402). 3,4–Methylenedioxy-Nethylamphetamine (7404). 3,4– Methylenedioxymethamphetamine (MDMA) (7405). 4–Methoxyamphetamine (7411) ... Bufotenine (7433) ......................... Diethyltryptamine (7434) .............. Dimethyltryptamine (7435) ........... Psilocybin (7437) .......................... Psilocyn (7438) ............................. N-Ethyl-1-phenylcyclohexylamine (7455). N-Benzylpiperazine (BZP) (7493) Trifluoromethylphenyl) Piperazine (7494). Heroin (9200) ............................... Normorphine (9313) ..................... Etonitazene (9624) ....................... Amphetamine (1100) .................... Methamphetamine (1105) ............ Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Secobarbital (2315) ...................... Glutethimide (2550) ...................... Nabilone (7379) ............................ Phencyclidine (7471) .................... Cocaine (9041) ............................. Codeine (9050) ............................. Diprenorphine (9058) ................... Oxycodone (9143) ........................ Hydromorphone (9150) ................ Diphenoxylate (9170) ................... Ecgonine (9180) ........................... Ethylmorphine (9190) ................... Hydrocodone (9193) ..................... Levorphanol (9220) ...................... Meperidine (9230) ........................ Methadone (9250) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273). Morphine (9300) ........................... Thebaine (9333) ........................... Opium powdered (9639) .............. Oxymorphone (9652) ................... Fentanyl (9801) ............................ PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II II II II II II II II II The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Sigma Aldrich Manufacturing LLC to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Sigma Aldrich Manufacturing LLC to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and § 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: November 28, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–20742 Filed 12–6–06; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated July 10, 2006, and published in the Federal Register on July 24, 2006, (71 FR 41838–41839), Sigma Aldrich Research BioChemicals, Inc., 1–3 Strathmore Road, Natick, Massachusetts 01760, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: Drug Cathinone (1235) ............... Methcathinone (1237) ........ Aminorex (1585) ................ Alpha-ethyltryptamine (7249). Lysergic acid diethylamide (7315). Tetrahydrocannabinols (7370). E:\FR\FM\07DEN1.SGM 07DEN1 Schedule I I I I I I 70990 Federal Register / Vol. 71, No. 235 / Thursday, December 7, 2006 / Notices Drug sroberts on PROD1PC70 with NOTICES 4–Bromo–2,5– dimethoxyampheta- mine (7391). 4–Bromo-2,5dimethoxyphenethylamine (7392). 2,5–Dimethoxyamphetamine (7396). 3,4– Methylenedioxyamphetamine (7400). N-Hydroxy-3,4methylenedioxyamphetamine (7402). 3,4–Methylenedioxy-Nethylamphetamine (7404). 3,4–Methylenedioxymethamphetamine (MDMA) (7405). 1–[1–(2– Thienyl)cyclohexyl]piperidine (TCP) (7470). 1–Benzylpiperazine (BZP) (7493). Heroin (9200) ..................... Normorphine (9313) .......... Amphetamine (1100) ......... Methamphetamine (1105) Nabilone (7379) ................. 1–Phenylcyclohexylamine (7460). Phencyclidine (7471) ......... Cocaine (9041) .................. Codeine (9050) .................. Diprenorphine (9058) ......... Ecgonine (9180) ................ Levomethorphan (9210) .... Levorphanol (9220) ........... Meperidine (9230) ............. Metazocine (9240) ............. Methadone (9250) ............. Morphine (9300) ................ Thebaine (9333) ................ Levo-alphacetylmethadol (9648). Carfentanil (9743) .............. Fentanyl (9801) ................. the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Schedule I Dated: November 28, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–20737 Filed 12–6–06; 8:45 am] I I I BILLING CODE 4410–09–P I DEPARTMENT OF JUSTICE I Drug Enforcement Administration I Importer of Controlled Substances; Notice of Registration I By Notice dated July 10, 2006, and published in the Federal Register on July 24, 2006, (71 FR 41839–41840), Stepan Company, Natural Products Department, 100 W. Hunter Avenue, Maywood, New Jersey 07607, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Coca Leaves (9040), a basic class of controlled substance listed in schedule II. The company plans to import the listed controlled substance for the manufacture of bulk controlled substances and distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Stepan Company to import this basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Stepan Company to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security system, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. I I I II II II II II II II II II II II II II II II II II II II The company plans to manufacture reference standards. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Sigma Aldrich Research BioChemicals, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Sigma Aldrich Research BioChemicals, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, VerDate Aug<31>2005 18:18 Dec 06, 2006 Jkt 211001 Dated: November 28, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–20748 Filed 12–6–06; 8:45 am] BILLING CODE 4410–09–P PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated August 15, 2006 and published in the Federal Register on August 22, 2006, (71 FR 48948), Wildlife Laboratories, Inc., 1401 Duff Drive, Suite 400, Fort Collins, Colorado 80524, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Etorphine Hydrochloride (9059), a basic class of controlled substance listed in schedule II. The company plans to import the listed controlled substance for sale to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Wildlife Laboratories, Inc. to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Wildlife Laboratories, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Dated: November 28, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–20741 Filed 12–6–06; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Office of Justice Programs [OMB Number 1121–0309] Agency Information Collection Activities: Proposed Collection; Comments Requested ACTION: 60-Day Notice of Information Collection Under Review: International Terrorism Victim Expense Reimbursement Program Application. E:\FR\FM\07DEN1.SGM 07DEN1

Agencies

[Federal Register Volume 71, Number 235 (Thursday, December 7, 2006)]
[Notices]
[Pages 70989-70990]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-20737]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated July 10, 2006, and published in the Federal 
Register on July 24, 2006, (71 FR 41838-41839), Sigma Aldrich Research 
BioChemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760, 
made application by renewal to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of the basic classes of 
controlled substances listed in schedule I and II:

------------------------------------------------------------------------
                   Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)..........................  I
Methcathinone (1237)......................  I
Aminorex (1585)...........................  I
Alpha-ethyltryptamine (7249)..............  I
Lysergic acid diethylamide (7315).........  I
Tetrahydrocannabinols (7370)..............  I

[[Page 70990]]

 
4-Bromo-2,5-dimethoxyampheta- mine (7391).  I
4-Bromo-2,5-dimethoxyphenethylamine (7392)  I
2,5-Dimethoxyampheta- mine (7396).........  I
3,4-Methylenedioxyamphetamine (7400)......  I
N-Hydroxy-3,4-methylenedioxyamphetamine     I
 (7402).
3,4-Methylenedioxy-N-ethylamphetamine       I
 (7404).
3,4-Methylenedioxymeth- amphetamine (MDMA)  I
 (7405).
1-[1-(2-Thienyl)cyclohexyl]piperidine       I
 (TCP) (7470).
1-Benzylpiperazine (BZP) (7493)...........  I
Heroin (9200).............................  I
Normorphine (9313)........................  I
Amphetamine (1100)........................  II
Methamphetamine (1105)....................  II
Nabilone (7379)...........................  II
1-Phenylcyclohexylamine (7460)............  II
Phencyclidine (7471)......................  II
Cocaine (9041)............................  II
Codeine (9050)............................  II
Diprenorphine (9058)......................  II
Ecgonine (9180)...........................  II
Levomethorphan (9210).....................  II
Levorphanol (9220)........................  II
Meperidine (9230).........................  II
Metazocine (9240).........................  II
Methadone (9250)..........................  II
Morphine (9300)...........................  II
Thebaine (9333)...........................  II
Levo-alphacetylmethadol (9648)............  II
Carfentanil (9743)........................  II
Fentanyl (9801)...........................  II
------------------------------------------------------------------------

    The company plans to manufacture reference standards.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Sigma Aldrich Research BioChemicals, Inc. to manufacture the listed 
basic classes of controlled substances is consistent with the public 
interest at this time. DEA has investigated Sigma Aldrich Research 
BioChemicals, Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with State and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above 
named company is granted registration as a bulk manufacturer of the 
basic classes of controlled substances listed.

    Dated: November 28, 2006.
 Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-20737 Filed 12-6-06; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.